ALT vs NWS · rev $20.0K vs rev $9.03B
Altimmune Inc (ALT) versus NWS (NWS) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
NWS (NWS) common stock.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported NWS revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 6.8% from 2025-06-30 to 2026-06-30. NWS currently screens at market cap $0.
ALT currently screens at market cap $527.0M. NWS currently screens at market cap $0.
Not investment advice. Open the ALT and NWS stock pages for the full models.
Not investment advice.